VCU Pain And neuropathy Research Program Neuropharmacology of drug addiction and pain- nicotinic Lab

Joined June 2015
114 Photos and videos
Our latest in the Journal of Pain @TheJournal_Pain : A critical role for α7 nicotinic acetylcholine receptor signaling in myeloid lineage cells in chronic neuropathic and inflammatory pain responses sciencedirect.com/science/ar…

2
3
295
11 Jul 2025
Our latest on adolescent nicotine “Adolescent nicotine exposure affects later-life nicotine reward and withdrawal in mice” with the talented graduate student @BuzziBelle sciencedirect.com/science/ar…

1
3
283
Imad Damaj retweeted
2 Apr 2025
Check out this #PapersoftheWeek pick from @Edaksl14 and @ELSpharma’s Pharmacological Research about psychedelics psilocybin and DOI dose-dependently reversing pain-like behaviors through serotonergic receptor activity in mouse models of chronic pain bit.ly/4l2kRAj #PRF
1
4
1,956
30 Mar 2025
Check out our newest paper with the talented former Ph.D. Student @BD_Mckiver ! Astrocyte elevated gene-1 (AEG-1) in myeloid cells is a key driver for the development of chemotherapy-induced peripheral neuropathy. sciencedirect.com/science/ar…

6
13
1,195
18 Mar 2025
Just out: psychedelics in action! Our paper in collaboration with Javier Gonzalez-Maeso group and awesome members of the lab @BuzziBelle and Eda Köşeli demonstrating the long lasting effects of a single dose of psilocybin in mouse models of chronic pain. sciencedirect.com/science/ar…

8
21
1,708
31 Jan 2025
Join us on this interesting conference!
🚨 Exciting news! 🚨 We’re thrilled to announce the schedule & speaker lineup for our virtual conference on March 7, 2025! 🎉 Stay tuned for details, and get ready for an incredible event! 🔗 isrpsych.org/conferences #ISRP2025
2
222
Imad Damaj retweeted
21 Jan 2025
A new paper characterizing our novel nicotine vapor self administration mouse model alongside great scientists! @LoisAkinola @DamajLab sciencedirect.com/science/ar…

1
3
7
996
Imad Damaj retweeted
Harvard scientists are leaving academia for the private sector to fast-track biomedical breakthroughs. Michael Mina (eMed), Douglas Melton (Vertex), Stuart Schreiber (Arena Bioworks) cite funding delays & admin hurdles as key reasons. #BiomedicalResearch harvardmagazine.com/2025/01/…
12
87
486
59,564
13 Aug 2024
Awesome job by Yumna, a very talented medical student. She will be a wonderful physician scientist! Thanks also to Belle @BuzziBelle, a wonderful graduate student in the lab!
Excited to share that my latest, first-author publication is now online! A huge thanks to Dr. Damaj for his mentorship and to all the contributors that helped it come together! @DamajLab doi.org/10.1177/026988112412…
7
353
3 Jul 2024
Awesome work by @mfmiles and his lab!
A recent @npp_journal is out from Mignogna, Miles, & team: "Identification of novel genetic loci and candidate genes for progressive ethanol consumption in diversity outbred mice" nature.com/articles/s41386-0…
1
5
817
13 Jun 2024
Congratulations Julian! Nice work with several people in the Lab @BuzziBelle on spontaneous oxycodone withdrawal.
Happy to post my first paper in the Damaj lab @DamajLab 🍾🎊🎊 sciencedirect.com/science/ar…
3
12
830
29 May 2024
Thank you @EMRumney for the interview and thank you @sejordt for alerting us on this emerging health issue.
29 May 2024
Nicotine-like chemicals being used in vapes in the U.S. and beyond, such as 6-methyl nicotine, may be more potent and addictive than traditional nicotine. But they can also skirt regulations designed to control nicotine products. Here's my story: reuters.com/business/healthc…
4
192